缩写名/全名 |
EUR J MED CHEM
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
||||||||||||||||||||||||
ISSN号 | 0223-5234 | ||||||||||||||||||||||||
研究方向 | 化学-医药化学 | ||||||||||||||||||||||||
影响因子 | 2015:3.902, 2016:4.519, 2017:4.816, 2018:4.833, 2019:5.572, | ||||||||||||||||||||||||
出版国家 | FRANCE | ||||||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||||||
年文章数 | 956 | ||||||||||||||||||||||||
出版年份 | 0 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 平均4.3个月 来源Elsevier官网:平均7.4周 |
||||||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||||||
投稿链接 | http://ees.elsevier.com/ejmech/ | ||||||||||||||||||||||||
投稿官网 | http://www.elsevier.com/wps/find/journaldescription.cws_home/505813/description | ||||||||||||||||||||||||
h-index | 135 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0223-5234%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review Author: M. Xu, S.L. Wang, L. Zhu, P.Y. Wu, W.B. Dai, K.P. Rakesh Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, Vol.164, 448-470, DOI:10.1016/j.ejmech.2018.12.073 DOI |
2. | Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors Author: Jianjun Yu, Jieyu Liu, Daqiang Li, Lei Xu, Duidui Hong, Shan Chang, Lei Xu, Jia Li, Tao Liu, Yubo Zhou Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 423-439, DOI:10.1016/j.ejmech.2018.12.072 DOI |
3. | Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives Author: Hongjian Wang, Apeng Wang, Jian Gu, Lei Fu, Kai Lv, Chao Ma, Zeyu Tao, Bin Wang, Mingliang Liu, Huiyuan Guo, Yu Lu Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.165, 11-17, DOI:10.1016/j.ejmech.2018.12.071 DOI |
4. | Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs Author: Yuanyuan Shan, Ru Si, Jin Wang, Qingqing Zhang, Huaxin Zhou, Jie Song, Jie Zhang, Qinhua Chen Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 440-447, DOI:10.1016/j.ejmech.2018.12.067 DOI |
5. | Discovery of first-in-class thiazole-based dual FFA1/PPARδ agonists as potential anti-diabetic agents Author: Zheng Li, Yueming Chen, Zongtao Zhou, Liming Deng, Yawen Xu, Lijun Hu, Bing Liu, Luyong Zhang Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 352-365, DOI:10.1016/j.ejmech.2018.12.069 DOI |
6. | Discovery of 2-substituted-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors: Design, synthesis and biological evaluation Author: Jingwei Shao, Kongkai Zhu, Daohai Du, Yuanyuan Zhang, Hongrui Tao, Zhifeng Chen, Hualiang Jiang, Kaixian Chen, Cheng Luo, Wenhu Duan Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 317-333, DOI:10.1016/j.ejmech.2018.12.065 DOI |
7. | Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles Author: Xiao-Wu Dong, Jian-Kang Zhang, Lei Xu, Jin-Xin Che, Gang Cheng, Xiao-Bei Hu, Li Sheng, An-Hui Gao, Jia Li, Tao Liu, Yong-Zhou Hu, Yu-Bo Zhou Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 602-614, DOI:10.1016/j.ejmech.2018.12.064 DOI |
8. | Optimization of novel benzofuro[3,2-b]pyridin-2(1H)-one derivatives as dual inhibitors of BTK and PI3Kδ Author: Linyi Liu, Xinyu Li, Yu Cheng, Lianjian Wang, Huizhu Yang, Jiurong Li, Siying He, shuangjie Wu, Qianqian Yin, Hua Xiang Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 304-316, DOI:10.1016/j.ejmech.2018.12.055 DOI |
9. | Triptolide-targeted delivery methods Author: Hongtao Xu, Bo Liu Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 342-351, DOI:10.1016/j.ejmech.2018.12.058 DOI |
10. | ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway Author: Faiz-Ur Rahman, Amjad Ali, Hong-Quan Duong, Inam Ullah Khan, Muhammad Zeeshan Bhatti, Zhan-Ting Li, Hui Wang, Dan-Wei Zhang Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 546-561, DOI:10.1016/j.ejmech.2018.12.052 DOI |
|
|